Story · Medicine & Biotech

Editors’ Picks, November 2026: Less Toxic Immunotherapy, Targeting the Breast Cancer Microenvironment, Clinical Trials, and More

1 outlet · first reported by AACR News on

We hope you’re hungry, because this month, we have quite a feast for you: a groaning board of piping-hot research articles, specially selected by the editors of the 10 peer-reviewed journals of the American Association for Cancer Research (AACR). Savor a study of how immune checkpoint inhibitor… (AACR News)

Coverage, in order

  1. AACR News indie observational
    Editors’ Picks, November 2026: Less Toxic Immunotherapy, Targeting the Breast Cancer Microenvironment, Clinical Trials, and More

    We hope you’re hungry, because this month, we have quite a feast for you: a groaning board of piping-hot research articles, specially selected by the editors of the 10 peer-reviewed journals of the American Association for Cancer Research (AACR). Savor a study of how immune checkpoint inhibitor…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.